Log In
Print
BCIQ
Print
Print this Print this
 

POL6326

  Manage Alerts
Collapse Summary General Information
Company Polyphor Ltd.
DescriptionCXC chemokine receptor 4 (CXCR4) inhibitor
Molecular Target CXC chemokine receptor 4 (CXCR4) (NPY3R)
Mechanism of ActionCXC chemokine receptor 4 (CXCR4) antagonist
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase II
Standard IndicationStem cell transplant
Indication DetailsHematopoietic stem cell transplant (HSCT)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today